That decision is important from a humanitarian perspective, not to mention its potential ramifications in the pharma/ biotech sector and the FDA. It is definitely worthwhile reading.
Below is a link to the court's opinions in full, a 2-1 majority:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.